Skip to content
MarketScale
‹ Back to IndustriesSciences

VTOL’s Role in the Future of Public Safety

Romeo Durscher is the Vice President of Public Safety at Auterion, and he shared his insights regarding VTOL – vertical takeoff and landing. “In 2016, I got exposed to VTOL, vertical takeoff and landing platforms, for the first time. I was really intrigued by this concept. I already, in the back of my mind,…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · AuterionAviationRomeo DurscherRomeo Durscher Video
Share

Key takeaways

01

Romeo Durscher is the Vice President of Public Safety at Auterion, and he shared his insights regarding VTOL – vertical takeoff and landing.

02

“In 2016, I got exposed to VTOL, vertical takeoff and landing platforms, for the first time.

03

I was really intrigued by this concept.

Romeo Durscher is the Vice President of Public Safety at Auterion, and he shared his insights regarding VTOL – vertical takeoff and landing.

“In 2016, I got exposed to VTOL, vertical takeoff and landing platforms, for the first time. I was really intrigued by this concept. I already, in the back of my mind, had visions of how this could be utilized in enterprise, especially in public safety.

Now, having been at Auterion for a few months and having had the opportunity to really dig into some of the battery-powered drones, I am super excited.

Last week, for example, I spent several days in the desert testing the quantum systems vector. Vector is a beautiful victo platform, German engineered, amazingly put together with a tremendous amount of capabilities.

And, thanks to the Auterion-powered concept data flight logs, as well as live camera views with edge computing abilities on the aircraft, we live streamed to into the Auterion suite. So, it’s an amazing tool to have.

What really excited me, though, was that we did a lot of testing in high-wind environments to, in essence, fine tune our Auterion enterprise for flight control firmware.

And that is extremely helpful because, now, we standardize all of this. So that, no matter if you’re flying a VTOL or a multi-rotor, there is one user interface, there’s one radio, it’s standardized.

And that, in combination with the little capabilities, brings a whole new aspect into public safety.

There are multiple times when we have multi-hour incidents, like a hazardous material incident or a natural disaster, and we need a high level of situational awareness or overview of the scene. That’s where a VTOL will come in handy, fly for 90 minutes to two hours up there, and show us live what is happening.

While we’re still utilizing multi-rotors for closer-to-the-ground missions, those two will work together. Not only that, but the crew and the aircraft will be above that. And this is going to be a layered approach.

The benefits are tremendous, especially when you have the ability to get not only your live footage from the drone anywhere where you need to have it, but also very important health data, flight logs in real time from the aircraft, and more that allow you to do a tremendous amount of risk mitigation and decision-making capabilities on the ground.

I am very, very excited about this development. And we will see much more about integration in public safety.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

Hi, my name is Romeo dorsetshire without tarion, I'm the vice president of public safety in 2016, I got exposed to veto the vertical takeoff and landing platforms for the first time. And I was really intrigued by this concept. I already, in the back of my mind, had visions of how this could be utilized in enterprise, especially in public safety. Now, having been at attarian for a few months and having had the opportunity to really dig into some of the attari and powered drones, I am super excited. Last week, for example, I spent several days in the desert testing the kwanten systems. Vector vector is a beautiful victo platform, German engineered, amazingly put together with a tremendous amount of capabilities. And Thanks to the attarian powered concept data flight logs as well as lifegem camera views with on edge computing abilities on the aircraft, our life streamed to into the attarian suite. So it's an amazing tool to have. What really excited me, though, was that we did a lot of testing in high wind environments to in essence, fine tune our attari and enterprise for flight control firmware. And that is extremely helpful because now we standardize all of this. So that no matter if you're flying a vitol or a multi roder, there is one user interface, there's one radio, it's standardized. And that in combination with the little capabilities, brings a whole new aspect into public safety. There are multiple times when we have multi hour incidents like a hazardous material incident or a natural disaster, and we need a high level situational awareness or overview of the scene. That's where a vtol will come in handy, fly for 90 minutes to two hours up there, showing us live. What is happening. While we're still utilizing multi rotors for closer to the ground missions, those two will work together. Not only that, but crew, the aircraft will be above that. And this is going to be a layered approach. And the benefits are tremendous, especially when you have the ability to get not only your life footage from the drone anywhere where you need to have it, but also very important health data, flight logs in real time from the aircraft that allows you to do a tremendous amount of risk mitigation and decision making capabilities on the ground. I am very, very excited about this development. And we will see much more about little integration in public safety.

About the author

S
Sciences

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512